A Trial of Radial EBUS Versus VBN for the Peripheral Pulmonary Lesions

Launched by ILYA SIVOKOZOV · Feb 13, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at different methods to help doctors examine small areas in the lungs, known as peripheral pulmonary lesions, which could be signs of lung cancer, tuberculosis, or pneumonia. The study aims to compare three techniques: virtual bronchoscopy (a special imaging method), radial endobronchial ultrasound (a technique that uses sound waves), and a combination of both. This research is important because finding these lesions early can lead to better treatment options for patients.

To participate in this trial, you need to be an adult over 18 years old with newly diagnosed peripheral pulmonary lesions that haven't been confirmed yet. These lesions should be between 5 and 40 millimeters in size, and you'll need to have a recent chest CT scan. The trial is currently recruiting participants, so if you qualify, you can expect to undergo a navigational bronchoscopy, which is a procedure to see the lungs more clearly. It's important to note that if you have certain health issues or have had other types of cancer in the last three years, you may not be eligible.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients with newly diagnosed unverified solitary or multiple (up to 3) peripheral pulmonary lesions (PPLs)
• • 2. PPL size 5 - 40 mm
• • 3. Actual chest CT scan (\<31 days prior to navigation bronchoscopy), collimation 1 mm, pulmonary window, DICOM format
• • 4. Age \> 18 years
• • 5. Signed Informed consent form
• • 6. Willing and ability to undergone a navigational bronchoscopy
• Exclusion Criteria:
• • 1. Unability to undergone navigation bronchoscopy for any reason
• • 2. Any malignant disease during last 36 months
• • 3. Known central endobronchial lesion of any cause
• • 4. HIV-infection